Institution

CDC updates guidance page on clinical care for ADHD in children

October 21, 20261 min read

Key finding

The CDC directs clinicians to diagnose childhood ADHD using DSM-5-TR criteria and to follow the AAP clinical practice guideline for evaluation and treatment.

The US Centers for Disease Control and Prevention (CDC) updated a reference page for healthcare providers on diagnosing and treating ADHD in children. The page directs clinicians to use the DSM-5-TR criteria—a standard diagnostic framework that lists the symptoms and patterns doctors look for when identifying ADHD—and recommends following the American Academy of Pediatrics (AAP) clinical practice guideline for evaluation and treatment decisions.

This update pulls together existing clinical standards into one place rather than presenting new research findings. It applies to US healthcare providers treating children and does not address adults or ADHD care outside the United States.

The CDC page serves as a reference tool to help clinicians apply established diagnostic and treatment methods consistently. It does not report original research results or clinical trial data that would show whether one treatment approach works better than another.

Limitations

This is an updated reference page, not original research. It summarizes existing diagnostic criteria and clinical guidelines applicable to US pediatric practice only. Readers seeking evidence about which treatments work best or how outcomes compare would need to consult original clinical research, not this guidance consolidation.

Source

Published: October 21, 2026

Read the original

Information, not medical advice. This summary does not replace advice from a health professional.